跳至主要内容
临床试验/JPRN-UMIN000038108
JPRN-UMIN000038108已完成未知

Randomized controlled trial on the effectiveness of acupuncture for peripheral neuropathy by taxane anticancer drug treatment (multicenter collaborative research) - AcuNEXT

Shimane University0 个研究点目标入组 105 人开始时间: 2019年9月26日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
105

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Peripheral neuropathy falls under any of the following. Neurologic symptoms that may be caused by sciatica or radiculopathy Neurologic symptoms thought to be caused by peripheral nerve strangulation such as tarsal tunnel syndrome Extremity sensory abnormalities that may be caused by cerebrovascular disorders Peripheral peripheral circulatory disturbance based on obstructive arteriosclerosis or Raynaud's disease Diabetic neuropathy Numbness worsens after bathing. 2) It is difficult to receive acupuncture due to metal allergy. 3) Major organ functions such as liver function, kidney function, pulmonary function, and hemostatic function are severely impaired 4) A woman who is or may be pregnant. 5) Concomitant with psychosis or symptom, it is difficult to understand clinical trials. 6) In addition, the doctor responsible for research (sharing) determined that it was inappropriate.

研究者

相似试验